Chapter 11 New Reward - ITG Human Genetin
After the words fell, the picture gradually became blurry.
[The simulation of the plot of Blood War is over]
[Completion 100%]
[Achieve the ending: The benevolence of the doctor]
[Score for this simulation: S]
[Reward: 10 energy points]
[Reward: "ITG recombinant human myelopoietin" crystal form patent and production process. 】
[Reward: "ITG Recombinant Human Myelopoietin" pharmacokinetics, toxicokinetics, ethics, acute toxicity, and chronic toxicity data analysis materials. 】
[Reward: Complete clinical phase I and II data of "ITG recombinant human myelopoietin". 】
ITG recombinant human myelopoietin?
Looking at the long list of rewards, Zhang Yang’s eyes fell on the most critical drug reward.
What is this?
When he opened the instruction manual and looked at it, he jumped up.
Holy shit!
Is this a drug that can regenerate new bone marrow stem cells through recombination to cure "aplastic anemia"? !
Complete cure? !
Another problem!
Zhang Yang's breathing became rapid.
As we all know, the biggest difference between aplastic anemia and leukemia is that aplastic anemia is an autoimmune disease, which is caused by problems with one's own bone marrow stem cells!
Therefore, unlike leukemia or cancer, aplastic anemia can be cured by cutting out the bad lesions through chemotherapy, targeted drugs or surgery.
Aplastic anemia requires lifelong medication and is almost impossible to cure!
And now...!
Hiss! !
Zhang Yang couldn't wait to withdraw the reward, but as soon as he had the idea, he suddenly thought of the little boy's sister.
"Let's watch the ending first!"
Entering the replay, this time Zhang Yang did not return to the void, but automatically entered the God's perspective.
Five minutes later, the speeding ambulance did not drive into the emergency center, but quickly arrived downstairs at the Second Inpatient Department.
Because of the advance arrangements made by Director Feng of the Department of Hematology, the hematologists were already ready, and the patient was immediately pushed into the sterile ward for individual rescue.
Three hours later, the patient's consciousness gradually returned to consciousness from the fuzzy state, and the CT results also showed that the amount of cerebral hemorrhage was less than 5ML.
This means that the girl does not need a craniotomy.
24 hours later, the patient's vital signs were stable and the danger to his life was relieved. At the same time, treatment for aplastic anemia was officially started.
Zhang Yang breathed a sigh of relief, finally saved!
The screen ends here, and a text summary appears in front of you.
[The treatment of aplastic anemia is the same as that of most blood diseases. There are two options: drug treatment and hematopoietic stem cell transplantation. 】
[Since transplantation treatment costs hundreds of thousands of yuan, the patient ultimately chose conservative drug treatment. 】【However, aplastic anemia is an immune disease that cannot be completely cured. It not only requires long-term combined treatment with multiple drugs, but also the cost of drug treatment is not low, which makes this already suffering family even worse. 】
【Fortunately, there is medical insurance that can reimburse part of it, and fortunately the girl is also very strong; five years later, the little boy successfully entered a key university with the support of his sister, and everything started to look good. direction of development. 】
【But... the bad luck didn't seem to let the two siblings go. 】
[Because no bone marrow transplant was performed, my sister’s severe aplastic anemia suddenly recurred again...]
[There is no miracle this time...]
[The girl is unfortunate, but also lucky. 】
[The mortality rate of severe aplastic anemia is extremely high, and the five-year survival rate is only 10%. Compared with other patients, she is lucky enough. 】
“…”
Zhang Yang was silent and stunned.
Although he knew it was just a simulation, at this moment, he could not suppress the pain and sadness in his heart.
After half an hour, he gradually recovered and passed the "ITG human myelopoietin" patent into his mind with regret.
The complicated and redundant test data are also downloaded to the personal computer.
Exiting the simulator, Zhang Yang lay on the sofa, staring at the ceiling blankly.
This was the first time he truly understood "aplastic anemia".
After lying down for a while, he sat up again, then took out his laptop and started searching for information about "aplastic anemia".
[Currently, there are nearly 6 million patients with blood diseases in China, of which about 1.5 million are "aplastic anemia". 】
[After treatment, some patients have effectively controlled their condition and can live and work normally. Their blood routine indicators are basically normal and their quality of life is good. 】
【However, the vast majority of patients are in serious condition, with frequent infections, bleeding and other symptoms, and require long-term dependence on blood transfusions and drug treatment to maintain life. 】
【These patients have low immunity and weak body, unable to live and work normally, and women cannot even have children. 】
[At present, the cost of treating "aplastic anemia" in China is also relatively high. The most basic monthly treatment cost is about 2,000-3,000 yuan. It is impossible to estimate if you take imported drugs...]
See the end, Zhang Yang I closed my notebook quietly, and "ITG human myelopoietin" came to my mind.
If "Avatrombopag" is the world's top drug for treating blood diseases and can maintain the patient's blood image to the maximum extent, then!
Only "ITG Human Myelopoietin" can completely change the fate of all patients with "aplastic anemia"!
He clenched his fists.
But the next second, he calmed down.
We will definitely no longer be able to apply for clinical trials in the short term.
If the development of "Avatrombopag" can be explained by accidental discovery, then just a few weeks later a drug that can completely cure "aplastic anemia" was developed, then It's simply outrageous.
By then, everyone will see that there is something wrong with Qingshan Pharmaceutical.
The only solution is to wait for "Avatrombopag Qingshan" to complete clinical trials!
(End of this chapter)